Literature DB >> 16640656

Peroxisome proliferator-activated receptor alpha, delta, gamma1 and gamma2 expressions are present in human monocyte-derived dendritic cells and modulate dendritic cell maturation by addition of subtype-specific ligands.

M A Jakobsen1, R K Petersen, K Kristiansen, M Lange, S T Lillevang.   

Abstract

It has recently been shown by Chang et al. (J Immunol 2000;165:3584-91) that the maturation of dendritic cells (DC) in the presence of long-chain fatty acids redirects DC into Th0/Th2-inducing cells suggesting the involvement of a receptor for long-chain fatty acids like members of the peroxisome proliferator-activated receptors (PPAR) superfamily. Here, we show that immature and mature monocyte-derived DC (Mo-DC) express PPARalpha, PPARdelta, PPARgamma1 and PPARgamma2 mRNA with the highest level of PPARgamma1 mRNA. We were only able to observe the expression of PPARgamma1 protein by Western blotting probably because the protein level of the other subtypes is below the detection limit. Synthetic ligands specific for PPARalpha, PPARdelta or PPARgamma added at day 0-6 have similar effect on the maturation of Mo-DC driving the maturation of Mo-DC with atypical phenotype, reduced expression of IL-10, IL-12 p35 and IL-12 p40 mRNA and with reduced stimulatory effects in mixed leucocyte reaction (MLR). Our data suggest that naturally occurring PPAR ligands like fatty acids and fatty acid derivates have anti-inflammatory effects by redirecting DC into a less stimulatory mode.

Entities:  

Mesh:

Substances:

Year:  2006        PMID: 16640656     DOI: 10.1111/j.1365-3083.2006.01745.x

Source DB:  PubMed          Journal:  Scand J Immunol        ISSN: 0300-9475            Impact factor:   3.487


  16 in total

1.  Atypical activation of dendritic cells by Plasmodium falciparum.

Authors:  Anton Götz; Mei San Tang; Maureen C Ty; Charles Arama; Aissata Ongoiba; Didier Doumtabe; Boubacar Traore; Peter D Crompton; P'ng Loke; Ana Rodriguez
Journal:  Proc Natl Acad Sci U S A       Date:  2017-11-21       Impact factor: 11.205

Review 2.  Role of dendritic cell metabolic reprogramming in tumor immune evasion.

Authors:  Michael P Plebanek; Michael Sturdivant; Nicholas C DeVito; Brent A Hanks
Journal:  Int Immunol       Date:  2020-06-26       Impact factor: 4.823

3.  Peroxisome proliferator-activated receptor delta agonists inhibit T helper type 1 (Th1) and Th17 responses in experimental allergic encephalomyelitis.

Authors:  Saravanan Kanakasabai; Wanida Chearwae; Crystal C Walline; Wade Iams; Suzanne M Adams; John J Bright
Journal:  Immunology       Date:  2010-04-06       Impact factor: 7.397

4.  Ligand activation of peroxisome proliferator-activated receptor beta/delta (PPARbeta/delta) attenuates carbon tetrachloride hepatotoxicity by downregulating proinflammatory gene expression.

Authors:  Weiwei Shan; Prajakta S Palkar; Iain A Murray; Emily I McDevitt; Mary J Kennett; Boo Hyon Kang; Harriet C Isom; Gary H Perdew; Frank J Gonzalez; Jeffrey M Peters
Journal:  Toxicol Sci       Date:  2008-07-12       Impact factor: 4.849

Review 5.  Role of peroxisome-proliferator-activated receptor beta/delta (PPARbeta/delta) in gastrointestinal tract function and disease.

Authors:  Jeffrey M Peters; Holly E Hollingshead; Frank J Gonzalez
Journal:  Clin Sci (Lond)       Date:  2008-08       Impact factor: 6.124

6.  Pollen lipidomics: lipid profiling exposes a notable diversity in 22 allergenic pollen and potential biomarkers of the allergic immune response.

Authors:  Mohamed Elfatih H Bashir; Jan Hsi Lui; Ravishankar Palnivelu; Robert M Naclerio; Daphne Preuss
Journal:  PLoS One       Date:  2013-02-28       Impact factor: 3.240

7.  Ligand activation of peroxisome proliferator-activated receptor-beta/delta(PPARbeta/delta) inhibits cell growth of human N/TERT-1 keratinocytes.

Authors:  Andrew D Burdick; Moses T Bility; Elizabeth E Girroir; Andrew N Billin; Timothy M Willson; Frank J Gonzalez; Jeffrey M Peters
Journal:  Cell Signal       Date:  2007-01-03       Impact factor: 4.850

8.  Nuclear control of the inflammatory response in mammals by peroxisome proliferator-activated receptors.

Authors:  Stéphane Mandard; David Patsouris
Journal:  PPAR Res       Date:  2013-03-07       Impact factor: 4.964

9.  Role of Peroxisome Proliferator-Activated Receptor-γ in Vascular Inflammation.

Authors:  Kousei Ohshima; Masaki Mogi; Masatsugu Horiuchi
Journal:  Int J Vasc Med       Date:  2012-07-24

10.  Peroxisome proliferator-activated receptor-beta/delta (PPARbeta/delta) ligands inhibit growth of UACC903 and MCF7 human cancer cell lines.

Authors:  Elizabeth E Girroir; Holly E Hollingshead; Andrew N Billin; Timothy M Willson; Gavin P Robertson; Arun K Sharma; Shantu Amin; Frank J Gonzalez; Jeffrey M Peters
Journal:  Toxicology       Date:  2007-11-04       Impact factor: 4.571

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.